Posted: July 18 2018
Author: CDPE
Comparing Models of Drug Checking Services in Canada
Models of drug checking services (DCS) in Canada differ in important ways, including targeted sub-populations of people who use drugs (who can access the service and when) and the technology used for analysis of samples (which impacts how long it takes to receive results and what information is available from the analysis). This resource aims to provide an overview of select DCS in Canada that are harmonizing research protocols and approaches for the purpose of ensuring nationwide comparability of collected evidence.
Related Content
Piloting and evaluating drug checking services in Toronto, Ontario
The pilot for Toronto’s Drug Checking Service, which checked and publicly reported on more than 10,000 samples between October 10, 2019, and June 30, 2023, was coordinated by the CDPE. While Toronto’s Drug Checking Service now operates from its own unit within MAP Centre for Urban Health Solutions at St. Michael’s Hospital, a site of Unity Health Toronto, the CDPE continues to work collaboratively with and conduct scientific research on the program.
View
Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications
We report the first detection of the psychoactive veterinary compound xylazine in Toronto, the largest urban center in Canada, by the city’s drug checking service.
View
Private: What’s in Toronto’s Drug Supply? Results from Samples Checked by Toronto’s Drug Checking Service: October 2019 – March 2020
Between October 10, 2019, when Toronto's drug checking service formally launched, and March 31, 2020, 543 samples were checked using mass spectrometry technologies (gas- and liquid-chromatography). This report details the results from the analysis of those samples.
View